Loading...
Chemical structure of AG-13958

GC35263

AG-13958

Also known as N-[2-fluoro-5-[[3-[(E)-2-pyridin-2-ylethenyl]-1H-indazol-6-yl]amino]phenyl]-2,5-dimethylpyrazole-3-carboxamide

AG-13958 (AG-013958), a potent VEGFR tyrosine kinase inhibitor, is used for treatment of choroidal neovascularization associated with age-related macular degeneration (AMD)

ChemicalCAS319460-94-1MW467.5FormulaC26H22FN7O
CAS number
319460-94-1
Molecular weight
467.5
Formula
C26H22FN7O
Solubility
DMSO： 5 mg/mL (10·70 mM; ultrasonic and warming and heat to 60°C)
InChIKey
JXSVVZKPEDIRTN-DHZHZOJOSA-N
Catalogue number
GC35263
Brand
GLPBIO
Computed properties PubChem CID 9934283 · XLogP 4.3 · TPSA 101 Ų · H-bond donors 3
XLogP
4.3
TPSA
101 Ų
H-bond donors
3
H-bond acceptors
6
Rotatable bonds
6
Heavy atoms
35

SMILES CC1=NN(C(=C1)C(=O)NC2=C(C=CC(=C2)NC3=CC4=C(C=C3)C(=NN4)/C=C/C5=CC=CC=N5)F)C

Computed descriptors from PubChem (CID 9934283), public domain. Identity cross-checked against the supplier's molecular formula and weight — verify before use.

Ordering in Israel

Lead time
Ships from the manufacturer to your lab in 8–14 business days; customs and cold chain handled by LABO Scientific.
Pricing
Quoted in ILS, excl. VAT. Add the item to your quote and we confirm the final price, usually the same business day.
Documents
Lot certificate of analysis and manufacturer SDS are emailed with your order confirmation.
Who we serve
Universities, hospitals and biotech companies across Israel. Research use only — not for diagnostic or therapeutic use.